IRVINE, Calif., Nov. 1, 2022 /PRNewswire/ — Edwards Lifesciences (NYSE: EW) today announced that it has executed an accelerated share repurchase agreement (“ASR”) to repurchase $750 million of Edwards’ common stock. With this transaction, Edwards has repurchased more than $1.7 billion of shares in 2022. Under the terms of this ASR, Edwards will receive an initial delivery […]
Other News
CathVision Announces Initiation of Clinical Study Evaluating Signal Complexity Algorithm
Study Advances Efforts to Launch CARDIALYTICS Suite of Analytic Tools COPENHAGEN, Denmark, Nov. 2, 2022 /PRNewswire/ — CathVision, a medical technology company developing innovative electrophysiology solutions to enhance clinical decision-making in the EP lab, today announced the investigation of the Signal Complexity™ algorithm designed to visualize and quantify atrial fibrillation (AF) complexity parameters in […]
ImpediMed Reaches Milestone of 500,000 Patient Tests Performed with the SOZO Digital Health Platform
CARLSBAD, Calif., Nov. 2, 2022 /PRNewswire/ — ImpediMed Limited (ASX: IPD) reached a milestone of 500,000 patient tests performed with the SOZO® Digital Health Platform. With over 1,100 devices in use globally, the pace of patient testing has accelerated with 100,000 patient tests performed in just the past six months. Product improvements, […]
Clario Extends Lead in Delivering Decentralized (DCT) and Hybrid Clinical Trials
New data shows Clario has helped more than 2.6 million patients participate in life changing clinical trials for innovative new medicines through decentralized and hybrid technology solutions More than 1000 compounds: Number of potential medicines tested using Clario remote data collection technologies Over 2.6 million patients: Number of participants in Clario DCTs […]
Semler Reports Third Quarter and Year-to-Date 2022 Financial Results
2022 Q3 quarterly HIGHLIGHTS compared to the corresponding period of 2021: Revenue was $14.0 million, same as the prior year period Net income was $3.7 million, or $0.55 per basic share and $0.46 per diluted share, compared to $4.2 million, or $0.61 per basic share and $0.51 per diluted share Cash and cash equivalents at September 30, 2022 increased to $45.5 million from $35.9 million SANTA CLARA, […]
Novo Nordisk Foundation grants DKK 25 million ($3.3 million) for completion of clinical trial to improve treatment outcomes for people with critical limb ischaemia
COPENHAGEN, Denmark, Nov. 2, 2022 /PRNewswire/ — The grant will enable leading international researchers to complete a clinical trial comparing the two most common treatment methods for preventing leg amputation among people with critical limb ischaemia. Critical limb ischaemia is a serious and debilitating disease that affects about 22 million people globally, […]
Shanghai Operation Robot announced the first Robot-assisted human clinical trial of biliary stent placement surgery
SHANGHAI, Nov. 2, 2022 /PRNewswire/ — Shanghai Operation Robot Co.,Ltd announced the results of its initial clinical trial of ERCP (Endoscopic retrograde cholangiopancreatography) robot in biliary stent placement surgery. It is the first Robot-assisted human clinical trial of biliary stent placement surgery in the world. The surgery was conducted by Aopeng Medical. The […]
ViewRay Announces Third Quarter 2022 Results
DENVER, Nov. 1, 2022 /PRNewswire/ — ViewRay, Inc. (Nasdaq: VRAY) (the “Company”) today announced financial results for the third quarter ended September 30, 2022. Third Quarter 2022 Highlights Total revenue for the third quarter 2022 was approximately $26.5 million, primarily from four revenue units, compared to approximately $19.2 million, primarily from three revenue units, in the third […]
Acutus Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CARLSBAD, Calif., Nov. 01, 2022 (GLOBE NEWSWIRE) — Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, granted equity awards on November 1, 2022 that were approved by the Compensation Committee of its Board of […]
CVRx Reports Third Quarter 2022 Financial and Operating Results
Third quarter 2022 revenue of $6.2 million, an 82% increase over prior year MINNEAPOLIS, Nov. 01, 2022 (GLOBE NEWSWIRE) — CVRx, Inc. (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular diseases, today announced its financial and operating results for […]
